Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Neurocrine Biosciences, Inc.

19% sales growth and 13.55% return on equity

Neurocrine Biosciences, Inc., a commercial-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of neurological, endocrine, and psychiatric disorders in the United States.

Neurocrine Biosciences, Inc.’s sales growth this year is expected to be 35.2% and 17.6% for next year.

Year-on-year quarterly revenue growth grew by 16.4%, now sitting on 1.04B for the twelve trailing months.

Neurocrine Biosciences, Inc.’s sales growth for the next quarter is 19%. The company’s growth estimates for the present quarter and the next is 68.6% and 28.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.55%.

Volatility

Neurocrine Biosciences, Inc.’s last day, last week, and last month’s average volatility was a positive 0.41%, a negative 0.44%, and a positive 0.05%, respectively.

Neurocrine Biosciences, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.55%, 2.83%, and 3.22%, respectively.

Neurocrine Biosciences, Inc.’s Stock Yearly Top and Bottom Value

Neurocrine Biosciences, Inc.’s stock is valued at $95.85 at 01:22 EST, way below its 52-week high of $136.26 and way above its 52-week low of $72.14.

Neurocrine Biosciences, Inc.’s Moving Average

Neurocrine Biosciences, Inc.’s worth is above its 50-day moving average of $94.64 and way under its 200-day moving average of $107.62.

2. The Joint Corp.

20.9% sales growth and 57.86% return on equity

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States.

The Joint Corp.’s sales growth this year is expected to be 20.4% and 23.9% for next year.

Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 55.52M for the twelve trailing months.

The Joint Corp.’s sales growth for the next quarter is 20.9%. The company’s growth estimates for the current quarter and the next is 55.6% and 33.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 57.86%.

Volatility

The Joint Corp.’s last day, last week, and last month’s average volatility was 1.98%, 0.24%, and 0.07%, respectively.

The Joint Corp.’s last day, last week, and last month’s high and low average amplitude percentage was 3.96%, 3.58%, and 3.96%, respectively.

The Joint Corp.’s Stock Yearly Top and Bottom Value

The Joint Corp.’s stock is valued at $26.26 at 01:22 EST, below its 52-week high of $27.91 and way above its 52-week low of $7.67.

The Joint Corp.’s Moving Average

The Joint Corp.’s worth is higher than its 50-day moving average of $26.00 and way above its 200-day moving average of $19.20.

3. AppFolio, Inc.

9.8% sales growth and 79.69% return on equity

AppFolio, Inc. provides industry-specific cloud-based business software solutions, services, and data analytics for the real estate and legal markets.

AppFolio, Inc.’s sales growth this year is anticipated to be 21.6% and 12.6% for next year.

Year-on-year quarterly revenue growth grew by 23.8%, now sitting on 304.99M for the twelve trailing months.

AppFolio, Inc.’s sales growth for the next quarter is 9.8%. The company’s growth estimates for the present quarter and the next is a negative 33.3% and 133.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 79.69%.

Volatility

AppFolio, Inc.’s last day, last week, and last month’s average volatility was a negative 1.00%, a positive 0.97%, and a positive 1.10%, respectively.

AppFolio, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.31%, 4.92%, and 4.00%, respectively.

AppFolio, Inc.’s Stock Yearly Top and Bottom Value

AppFolio, Inc.’s stock is valued at $180.61 at 01:22 EST, below its 52-week high of $186.23 and way higher than its 52-week low of $81.01.

AppFolio, Inc.’s Moving Average

AppFolio, Inc.’s worth is way higher than its 50-day moving average of $160.59 and way above its 200-day moving average of $156.60.

4. Restaurant Brands International Inc.

8.3% sales growth and 21.76% return on equity

Restaurant Brands International Inc. owns, operates, and franchises quick service restaurants under the Tim Hortons (TH), Burger King (BK), and Popeyes (PLK) brand names.

Restaurant Brands International Inc.’s sales growth this year is expected to be 9.6% and 5% for next year.

Year-on-year quarterly revenue growth declined by 8.3%, now sitting on 5.09B for the twelve trailing months.

Restaurant Brands International Inc.’s sales growth for the next quarter is 8.3%. The company’s growth estimates for the current quarter and the next is 55.6% and 29.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.76%.

Volatility

Restaurant Brands International Inc.’s last day, last week, and last month’s average volatility was 1.69%, 0.40%, and 0.39%, respectively.

Restaurant Brands International Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.96%, 1.60%, and 2.17%, respectively.

Restaurant Brands International Inc.’s Stock Yearly Top and Bottom Value

Restaurant Brands International Inc.’s stock is valued at $61.83 at 01:22 EST, below its 52-week high of $67.33 and way higher than its 52-week low of $25.08.

Restaurant Brands International Inc.’s Moving Average

Restaurant Brands International Inc.’s value is higher than its 50-day moving average of $59.85 and higher than its 200-day moving average of $56.82.

5. Eli Lilly and Company

13.7% sales growth and 131.77% return on equity

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide.

Eli Lilly and Company’s sales growth this year is anticipated to be 9.1% and 11.6% for next year.

Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 23.21B for the twelve trailing months.

Eli Lilly and Company’s sales growth for the next quarter is 13.7%. The company’s growth estimates for the present quarter and the next is 35.8% and 13.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 131.77%.

Volatility

Eli Lilly and Company’s last day, last week, and last month’s average volatility was a positive 0.05%, a negative 0.27%, and a positive 0.60%, respectively.

Eli Lilly and Company’s last day, last week, and last month’s high and low average amplitude percentage was 1.11%, 1.37%, and 2.29%, respectively.

Eli Lilly and Company’s Stock Yearly Top and Bottom Value

Eli Lilly and Company’s stock is valued at $166.58 at 01:22 EST, below its 52-week high of $173.90 and way above its 52-week low of $117.06.

Eli Lilly and Company’s Moving Average

Eli Lilly and Company’s value is higher than its 50-day moving average of $153.32 and above its 200-day moving average of $152.47.

6. Eaton Vance Corporation

11.8% sales growth and 8.84% return on equity

Eaton Vance Corp., through its subsidiaries, engages in the creation, marketing, and management of investment funds in the United States.

Eaton Vance Corporation’s sales growth this year is anticipated to be 6.4% and 8.8% for next year.

Year-on-year quarterly revenue growth grew by 4%, now sitting on 1.73B for the twelve trailing months.

Eaton Vance Corporation’s sales growth is a negative 0% for the present quarter and 11.8% for the next. The company’s growth estimates for the present quarter and the next is a negative 0% and 10%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.84%.

Volatility

Eaton Vance Corporation’s last day, last week, and last month’s average volatility was a negative 0.16%, a positive 0.71%, and a negative 0.07%, respectively.

Eaton Vance Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 0.80%, 1.59%, and 1.33%, respectively.

Eaton Vance Corporation’s Stock Yearly Top and Bottom Value

Eaton Vance Corporation’s stock is valued at $67.53 at 01:22 EST, below its 52-week high of $69.18 and way above its 52-week low of $23.59.

Eaton Vance Corporation’s Moving Average

Eaton Vance Corporation’s worth is above its 50-day moving average of $66.19 and way above its 200-day moving average of $48.93.

7. Camtek Ltd.

37.3% sales growth and 13.15% return on equity

Camtek Ltd.

Camtek Ltd.’s sales growth this year is expected to be 12.2% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 140.44M for the twelve trailing months.

Camtek Ltd.’s sales growth for the next quarter is 37.3%. The company’s growth estimates for the ongoing quarter and the next is 35.7% and 88.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.15%.

Volatility

Camtek Ltd.’s last day, last week, and last month’s average volatility was 0.92%, 0.97%, and 0.71%, respectively.

Camtek Ltd.’s last day, last week, and last month’s high and low average amplitude percentage was 4.71%, 4.80%, and 4.14%, respectively.

Camtek Ltd.’s Stock Yearly Top and Bottom Value

Camtek Ltd.’s stock is valued at $21.91 at 01:22 EST, under its 52-week high of $22.64 and way higher than its 52-week low of $6.27.

Camtek Ltd.’s Moving Average

Camtek Ltd.’s worth is way above its 50-day moving average of $19.67 and way higher than its 200-day moving average of $16.57.

8. QCR Holdings, Inc.

12.6% sales growth and 10.66% return on equity

QCR Holdings, Inc., a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services.

QCR Holdings, Inc.’s sales growth this year is expected to be 12.5% and 1.5% for next year.

Year-on-year quarterly revenue growth grew by 5.3%, now sitting on 208.6M for the twelve trailing months.

QCR Holdings, Inc.’s sales growth for the next quarter is 12.6%. The company’s growth estimates for the current quarter and the next is a negative 9.8% and 28.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.66%.

Volatility

QCR Holdings, Inc.’s last day, last week, and last month’s average volatility was a positive 0.53%, a negative 0.14%, and a positive 0.50%, respectively.

QCR Holdings, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 1.82%, 2.72%, and 2.81%, respectively.

QCR Holdings, Inc.’s Stock Yearly Top and Bottom Value

QCR Holdings, Inc.’s stock is valued at $39.59 at 01:22 EST, below its 52-week high of $43.90 and way above its 52-week low of $22.39.

QCR Holdings, Inc.’s Moving Average

QCR Holdings, Inc.’s value is higher than its 50-day moving average of $38.31 and way higher than its 200-day moving average of $32.04.

LEAVE A REPLY

Please enter your comment!
Please enter your name here